Cargando…

Allopregnanolone Promotes Regeneration and Reduces β-Amyloid Burden in a Preclinical Model of Alzheimer's Disease

Previously, we demonstrated that allopregnanolone (APα) promoted proliferation of rodent and human neural progenitor cells in vitro. Further, we demonstrated that APα promoted neurogenesis in the hippocampal subgranular zone (SGZ) and reversed learning and memory deficits in the male triple transgen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Shuhua, Wang, Jun Ming, Irwin, Ronald W., Yao, Jia, Liu, Lifei, Brinton, Roberta Diaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168882/ https://www.ncbi.nlm.nih.gov/pubmed/21918687 http://dx.doi.org/10.1371/journal.pone.0024293

Ejemplares similares

Regeneration in a Degenerating Brain: Potential of Allopregnanolone as a Neuroregenerative Agent
por: Ming Wang, Jun, et al.
Publicado: (2007)

Neuroregenerative Mechanisms of Allopregnanolone in Alzheimer’s Disease
por: Irwin, Ronald W., et al.
Publicado: (2012)

Frontiers in therapeutic development of allopregnanolone for Alzheimer’s disease and other neurological disorders
por: Irwin, Ronald W., et al.
Publicado: (2014)

Allopregnanolone Preclinical Acute Pharmacokinetic and Pharmacodynamic Studies to Predict Tolerability and Efficacy for Alzheimer’s Disease
por: Irwin, Ronald W., et al.
Publicado: (2015)

Allopregnanolone: Regenerative therapeutic to restore neurological health
por: Hernandez, Gerson D., et al.
Publicado: (2022)

Allopregnanolone-induced rise in intracellular calcium in embryonic hippocampal neurons parallels their proliferative potential
por: Wang, Jun Ming, et al.
Publicado: (2008)

Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function
por: Nilsen, Jon, et al.
Publicado: (2006)

Correction: Allopregnanolone Preclinical Acute Pharmacokinetic and Pharmacodynamic Studies to Predict Tolerability and Efficacy for Alzheimer's Disease
Publicado: (2015)

2-Deoxy-D-Glucose Treatment Induces Ketogenesis, Sustains Mitochondrial Function, and Reduces Pathology in Female Mouse Model of Alzheimer's Disease
por: Yao, Jia, et al.
Publicado: (2011)

The Allopregnanolone Response to Acute Stress in Females: Preclinical and Clinical Studies
por: Pisu, Maria Giuseppina, et al.
Publicado: (2022)

A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease
por: Ashton, Nicholas J., et al.
Publicado: (2019)

Ovariectomy Induces a Shift in Fuel Availability and Metabolism in the Hippocampus of the Female Transgenic Model of Familial Alzheimer's
por: Ding, Fan, et al.
Publicado: (2013)

Early Decline in Glucose Transport and Metabolism Precedes Shift to Ketogenic System in Female Aging and Alzheimer's Mouse Brain: Implication for Bioenergetic Intervention
por: Ding, Fan, et al.
Publicado: (2013)

Preclinical study of dimebon on β-amyloid-mediated neuropathology in Alzheimer's disease
por: Wang, Jun, et al.
Publicado: (2011)

Allopregnanolone in Postpartum Depression
por: Pinna, Graziano, et al.
Publicado: (2022)

Trajectories of Allopregnanolone and Allopregnanolone to Progesterone Ratio across the Six Subphases of Menstrual Cycle
por: Hamidovic, Ajna, et al.
Publicado: (2023)

Exploratory imaging outcomes of a phase 1b/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: Structural effects and functional connectivity outcomes
por: Raikes, Adam C., et al.
Publicado: (2022)

Optimized Turmeric Extract Reduces β-Amyloid and Phosphorylated Tau Protein Burden in Alzheimer’s Transgenic Mice
por: Douglas Shytle, R, et al.
Publicado: (2012)

Allopregnanolone and neurogenesis in the nigrostriatal tract
por: Wang, Jun Ming
Publicado: (2014)

Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer’s disease
por: Golzan, S.Mojtaba, et al.
Publicado: (2017)

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease
por: Norton, Daniel J., et al.
Publicado: (2020)

Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease
por: Kerbler, Georg M, et al.
Publicado: (2014)

Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease
por: Pascoal, T A, et al.
Publicado: (2017)

Amyloid β deposition and glucose metabolism on the long-term progression of preclinical Alzheimer's disease
por: Hatashita, Shizuo, et al.
Publicado: (2019)

Astrocyte reactivity influences the association of amyloid-β and tau biomarkers in preclinical Alzheimer’s disease
por: Pascoal, Tharick, et al.
Publicado: (2023)

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
por: Bellaver, Bruna, et al.
Publicado: (2023)

Chronic-Antibiotics Induced Gut Microbiota Dysbiosis Rescues Memory Impairment and Reduces β-Amyloid Aggregation in a Preclinical Alzheimer’s Disease Model
por: Bello-Medina, Paola C., et al.
Publicado: (2022)

Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation
por: Racine, Annie M., et al.
Publicado: (2014)

Allopregnanolone Reinstates Tyrosine Hydroxylase Immunoreactive Neurons and Motor Performance in an MPTP-Lesioned Mouse Model of Parkinson's Disease
por: Adeosun, Samuel O., et al.
Publicado: (2012)

Biosynthesis and biological action of pineal allopregnanolone
por: Tsutsui, Kazuyoshi, et al.
Publicado: (2014)

Allopregnanolone: An overview on its synthesis and effects
por: Diviccaro, Silvia, et al.
Publicado: (2021)

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease
por: Lim, Y Y, et al.
Publicado: (2015)

The preclinical amyloid sensitive composite to determine subtle cognitive differences in preclinical Alzheimer’s disease
por: Hahn, Alice, et al.
Publicado: (2020)

Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial
por: Hernandez, Gerson D., et al.
Publicado: (2020)

Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer’s disease
por: Sundaram, Guruswami SM, et al.
Publicado: (2015)

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease
por: Chatterjee, Pratishtha, et al.
Publicado: (2019)

Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer’s disease
por: Guzmán-Vélez, Edmarie, et al.
Publicado: (2022)

Interactions between Amyloid-β and Hemoglobin: Implications for Amyloid Plaque Formation in Alzheimer's Disease
por: Chuang, Jia-Ying, et al.
Publicado: (2012)

Preclinical and clinical study on [(18)F]DRKXH1: a novel β-amyloid PET tracer for Alzheimer’s disease
por: Xu, MiaoMiao, et al.
Publicado: (2021)

Plasmon-Activated Water Reduces Amyloid Burden and Improves Memory in Animals with Alzheimer’s Disease
por: Cheng, Chia-Hsiung, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dn2rnt3i98kgvniefedklenu9r